Search results
Moderna Files With FDA for Updated Covid Shot
Morningstar· 2 days agoBy Dean Seal Moderna has applied for the U.S. Food and Drug Administration to review its new Covid-19 shot that targets a variant of the virus recently flagged by regulators ...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 3 days agoThe stock price of Moderna has seen a sharp 27% rise in a month, while its peer – BioNTech – has...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via Yahoo Finance· 2 days agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 3 days agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 6 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 6 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map -Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 3 days agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
Moderna CFO sells $97,237 in stock amid performance unit vesting By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) reported a recent transaction by Chief Financial Officer James M. Mock,...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. -...
Morningstar· 2 days agoNEW YORK, June 7, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ ...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 6 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
